<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02884999</url>
  </required_header>
  <id_info>
    <org_study_id>APP</org_study_id>
    <nct_id>NCT02884999</nct_id>
  </id_info>
  <brief_title>Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines</brief_title>
  <acronym>APP</acronym>
  <official_title>Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This cohort study describes the epidemiology of trauma patients and their management in a
      French academic trauma center. It also aims to determine what recommendations from the
      European trauma guidelines is applied in routine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe trauma is responsible for more than 5 millions of deaths annually worldwide.
      Haemorrhagic shock secondary to uncontrolled bleeding is the leading cause of preventable
      death in this population, making bleeding and coagulopathy treatment a key element of the
      early phase of trauma management. European trauma guidelines have been developed to help
      clinicians in severe trauma management and improve bleeding and coagulopathy treatment in
      this population. Investigating who these guidelines are followed in routine is crucial to
      identify opportunities to improve early management of bleeding severe trauma patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients treated as per studied guidelines</measure>
    <time_frame>first 24 hours of trauma management</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">145</enrollment>
  <condition>Wounds and Injury</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>severe trauma patients</arm_group_label>
    <description>Severe trauma patients admitted to the site in the first 24 hours</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Severe trauma patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Trauma patients with injury severity score equal to or higher than 16 year old
             admitted to the Brest academic trauma centre within the 24 hours following the trauma

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CÃ©cile Aubron</last_name>
    <role>Study Director</role>
    <affiliation>CHRU de Brest</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de BRest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2016</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 31, 2016</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>trauma</keyword>
  <keyword>bleeding</keyword>
  <keyword>coagulopathy</keyword>
  <keyword>guidelines compliance</keyword>
  <keyword>recommendation</keyword>
  <keyword>transfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

